Sigma Healthcare (ASX:SIG) Long-Term Debt: A$1,802 Mil (As of Dec. 2025)


ASX:SIG Sigma Healthcare Ltd ASX:SIG
59 GF Score
Price A$2.80
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Long-Term Debt?

Sigma Healthcare ASX:SIG -0.71% 59 Long-Term Debt is A$1,802 Mil as of Dec. 2025. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Sigma Healthcare's Long-Term Debt for the quarter that ended in Dec. 2025 was A$1,802 Mil.

Sigma Healthcare's quarterly Long-Term Debt declined from Jul. 2024 (A$124 Mil) to Jan. 2025 (A$0 Mil) but then increased from Jan. 2025 (A$0 Mil) to Dec. 2025 (A$1,802 Mil).

Sigma Healthcare's annual Long-Term Debt declined from Jan. 2023 (A$80 Mil) to Jan. 2024 (A$0 Mil) but then stayed the same from Jan. 2024 (A$0 Mil) to Jan. 2025 (A$0 Mil).

Sigma Healthcare  (ASX:SIG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sigma Healthcare Long-Term Debt Related Terms

Sigma Healthcare Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Long-Term Debt Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 165.00 80.00 0.00 0.00

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.96 0.00 124.31 0.00 1,801.79
ASX:SIG
59GF Score
Sigma Healthcare Ltd ASX:SIG
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$1,802 Mil mean?
Sigma Healthcare (ASX:SIG) has a Long-Term Debt of A$1,802 Mil as of Dec. 2025.
Is Sigma Healthcare's Long-Term Debt too high?
Sigma Healthcare's current Long-Term Debt is A$1,802 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Long-Term Debt compare to MCK and CAH?
Sigma Healthcare's Long-Term Debt of A$1,802 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Sigma Healthcare's current Long-Term Debt is A$1,802 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.80 — trading 656.8% above its estimated fair value. The current Long-Term Debt is A$1,802 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Long-Term Debt is A$1,802 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.80 is trading 656.8% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Long-Term Debt: A$1,802 Mil
  • GF Value™: A$0.37 vs. price of A$2.80 (656.8% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Other Exchanges SIGGF:USA
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for ASX:SIG

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.80
Price
A$0.37
GF Value